"The Company is adhering to a value-building strat
Post# of 72440
(Total Views: 245)
Posted On: 02/08/2018 8:48:53 AM
"The Company is adhering to a value-building strategy born from discussions with larger pharmaceutical companies interested in Kevetrin, one of the world’s most advanced p53 drug candidates. Securing the right development partner for Kevetrin remains an important objective"
Boom!!!!
Boom!!!!
(6)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
Scroll down for more posts ▼